GlaxoSmithKline gets order for 60 million swine flu vaccines from the UK
May 17th, 2009 in Breaking News
GlaxoSmithKline gets order for 60m swine flu vaccines from the UK - Telegraph.
GlaxoSmithKline, the UK’s largest pharmaceutical company, has received an order for 60m swine flu vaccines from the UK Government. The company, which already manufactures one of the key anti-viral treatments for the virus, Relenza, has also received millions of orders from other European governments including France.
GSK, led by chief executive Andrew Witty, said it expects to manufacture a vaccine for the H1N1 strain as soon as a virus seed is made available by the World Health Organisation (WHO). The first doses are expected to be available four to six months later, subject to regulatory approval.
Source: GlaxoSmithKline gets order for 60m swine flu vaccines from the UK - Telegraph
May 17th, 2009 in Breaking News
GlaxoSmithKline gets order for 60m swine flu vaccines from the UK - Telegraph.
GlaxoSmithKline, the UK’s largest pharmaceutical company, has received an order for 60m swine flu vaccines from the UK Government. The company, which already manufactures one of the key anti-viral treatments for the virus, Relenza, has also received millions of orders from other European governments including France.
GSK, led by chief executive Andrew Witty, said it expects to manufacture a vaccine for the H1N1 strain as soon as a virus seed is made available by the World Health Organisation (WHO). The first doses are expected to be available four to six months later, subject to regulatory approval.
Source: GlaxoSmithKline gets order for 60m swine flu vaccines from the UK - Telegraph